- Hefte


 
Narkotikainformasjon er ikke tilgjengelig på det valgte språket, den opprinnelige teksten vises
Generisk:
Aktivt stoff:
ATC-gruppe: -
Aktivt innhold av virkestoffet:
pakking:
101803
11
DSN expects that this PDF will be checked completely regarding all text, lay-out, cutter, product code and bar-code. If no correction is com-municated about any of these items, DSN will consi-der this as being approved for further processing and ultimately printing. Due to li-mitations of digital proofingthis PDF cannot be seen as a final printing result.Questions? We are at your service.
De Schutter’Neroc nvBlancefloerlaan 179a
2050 Antwerp
Belgium
For strong results visit
Telephone: E-mail: info@ds-n.comwww.ds-n.com
Check printed size by aligning a ruler along this ruler.E.g.: When your ruler measures the printed ruler as 75 mm, this
means that this document was printed on 75%.
Che
ck ou

we
bsite
!
Separations
First Barcode Number2D Code NumberBarcode BWR (μm)
87169005538061018031130,00
Sign off operator:Date approval:Sign off DSN:Sign off customer:
Job NameDSN CodeDescriptionAccount
Account Executive Mail
P
Previous Pack CodeCorporate Code
ack CodeArtwork LoopRepro LoopPacktypePrinter
Technical PlanPrinting ProcessUnwind Direction
DateTime
Height (mm)Width (mm)Ink Coverage (%)Profile NumberProof Profile
ZCBV904545_RE.apZCBV90454500889CM Nutridrink Compact Protein Vanilla 4 x 125 ml NL, NO, CZDANONE TRADING BVsteffi.peeters@ds-n.com101803111015964056217321CLUSTEREINDHOVEN PACKAGING4x125mlOffset***4/25/141:19 PM+145.5+423.77290,00%PR0001559ISOcoatedv2-39L V5
+32 3 222 38 00
Material Code
***
This file was specifically produced for:
ZCBV904545_RE.ap/4/25/14 1:19 PM/
Cyan/
Magenta/
Yellow/
PANTONE 2655 C/
PANTONE 268 C/
Keyline/
V=+145.5H=+423.77
Lignende eller alternative produkter
ÿph㬐ؼ //-----------------REKLAMA--------------------- include("ads/full3.php"); //--------------------------------------------- ?>


Om prosjektet

Et fritt tilgjengelig ikke-kommersielt prosjekt med det formål å sammenligne legemiddelbruk på nivå av interaksjoner, bivirkninger samt narkotikapriser og deres alternativer

Mer informasjon